Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Emerging-Markets Bond · MFS

MFS Emerging Markets Debt Local Currency Fund A (EMLAX)

Ticker EMLAX · · Holdings as of Jul 31, 2026

Expense ratio
1.11%$111/yr per $10k
5-yr return
+0.6%annualized
1-yr return
+14.1%as of Dec 2025
Net assets
$528.8Mall share classes
Holdings
239

Bottom line

Is EMLAX a good fund? The bottom line

EMLAX is a share class of MFS Emerging Markets Debt Local Currency Fund, an actively managed emerging-markets bond mutual fund from MFS.

It charges 1.11% — about $111 a year on every $10,000 invested, more expensive than 66% of emerging-markets bond funds we track.

It returned +14.1% over one year, +0.6% a year over five years, +3.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $529 million in net assets and 239 holdings, its largest position is MFS Institutional Money Market Portfolio (6.9%) and the top 10 make up 38.3% of the portfolio.

This share class carries a front-end sales charge of up to 4.25%; a no-load class or ETF alternative can avoid it.

What stands out

  • Broadly diversified (239 holdings)

What to watch

  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 4.25%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What EMLAX invests in

The funds investment objective is to seek total return with an emphasis on high current income, but also considering capital appreciation.

MFS (Massachusetts Financial Services Company, the funds investment adviser) normally invests at least 80% of the funds net assets in debt instruments of issuers that are tied economically to emerging market countries and denominated in local currencies, and derivative instruments with similar economic characteristics to these instruments . Emerging markets are countries determined to have emerging market economies based on factors that demonstrate the country's financial and capital markets are in the development phase, including whether a particular country has a low- to middle-income economy according to the International Bank for Reconstruction and Development (the World Bank), the countrys designation by the International Monetary Fund as an emerging market, or the country's inclusion in an emerging market index. Emerging market countries include countries located in Latin…

From the fund's prospectus (filed Feb 26, 2026).

EMLAX performance

Fund calendar-year total returns, 2016–2025 2016: +9.5%; 2017: +14.4%; 2018: −6.4%; 2019: +15.8%; 2020: +2.4%; 2021: −8.3%; 2022: −9.0%; 2023: +13.2%; 2024: −4.4%; 2025: +19.2% +9% 2016 +14% 2017 −6% 2018 +16% 2019 +2% 2020 −8% 2021 −9% 2022 +13% 2023 −4% 2024 +19% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
EMLAX+14.1%+0.6%+3.7%
Emerging-Markets Bond median+14.5%+1.6%+4.0%

Source: Fund prospectus, as of Dec 31, 2025

Full EMLAX performance history →

What EMLAX costs

On a $10,000 investment, EMLAX's 1.11% expense ratio costs about $111 a year. The prospectus estimates $1,860 in total costs over 10 years (assuming 5% annual returns). The median emerging-markets bond fund charges 0.92%.

See the full EMLAX fee table →

EMLAX top 10 holdings

#Holding% of fund
1MFS Institutional Money Market Portfolio6.88%
2Mex Bonos Desarr Fix Rt5.86%
3Indonesia Government4.69%
4Republic Of South Africa3.81%
5Nota Do Tesouro Nacional3.75%
6Mex Bonos Desarr Fix Rt3.39%
7Malaysia Government3.05%
8India Government Bond2.36%
9China Government Bond2.30%
10China Development Bank2.25%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 38.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to EMLAX

More funds like EMLAX →

EMLAX FAQ

What is the expense ratio of EMLAX?
EMLAX's expense ratio is 1.11%, which works out to about $111 a year for every $10,000 invested. The prospectus estimates total costs of $1,860 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is EMLAX a good investment?
It depends on your goals, but the data points to: broadly diversified (239 holdings); 5-year return in the bottom quarter of its category; front-end sales load up to 4.25%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does EMLAX hold?
EMLAX's largest holdings are MFS Institutional Money Market Portfolio (6.9%), Mex Bonos Desarr Fix Rt (5.9%), Indonesia Government (4.7%), Republic Of South Africa (3.8%), Nota Do Tesouro Nacional (3.7%). It holds 239 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is EMLAX's 5-year return?
EMLAX returned +0.6% a year over the five years ending Dec 31, 2025, and +3.7% a year over ten years. Past performance does not guarantee future results.
Does EMLAX have a sales load?
Yes. EMLAX has a maximum front-end sales charge of 4.25%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages EMLAX?
EMLAX is offered by MFS through Mfs Series Trust X.